Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page
   


Home > Publications > Research Monographs > Diagnosis & Treatment of Drug Abuse in Family Practice

gray line


Diagnosis and Treatment of Drug Abuse in Family Practice

This American Family Physician monograph is made possible with federal funds from the National Institute on Drug Abuse. The information presented and opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its parent agencies, the National Institutes of Health or the United States Public Health Service; American Family Physician, or its publisher, the American Academy of Family Physicians. Any recommendation made by the authors must be weighed against the physician's own clinical judgment, based on but not limited to such factors as the patient's condition, benefits versus risks of suggested treatment and comparisons with recommendations of pharmaceutical compendia and other authorities.



Alan I. Trachtenberg, M.D., M.P.H.

Medical Officer, Science & Policy Analysis Branch
Office of Science Policy, Education & Legislation
National Institute on Drug Abuse
National Institutes of Health
Rockville, Maryland

Michael F. Fleming, M.D., M.P.H.

Director of the Office of Alcohol and Addiction Studies
Department of Family Medicine and Practice
University of Wisconsin, Madison, Medical School
Madison, Wisconsin


Prepared by Health Science Communications, Inc., New York, N.Y., based on interviews with and reviews by Alan I. Trachtenberg, M.D., M.P.H., and Michael F. Fleming, M.D., M.P.H. This American Family Physician monograph has been funded with federal funds from the National Institute on Drug Abuse, National Institutes of Health, under Contract No. N01DA3-2400.


The cover to the right depicts a stimulant drug (in green) such as cocaine or amphetamine penetrating the blood-brain barrier and causing an increase of extracellular dopamine (in white) in the nucleus accumbens. This causes behavioral reinforcement of drug self-administration.


Next Page >>

For additional information about NIDA, send e-mail to information@nida.nih.gov.



Illustration of a stimulant drug causing an increase of dopamine in the nucleus accumbens
Cover illustration by
Carol Donner, Tucson, Arizona




Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal